Journal article
Species-level, metagenomic and proteomic analysis of microbe-immune interactions in severe asthma
- Abstract:
-
Background: The airway microbiome in severe asthma has not been characterised at species-level by metagenomic sequencing, nor have the relationships between specific species and mucosal immune responses in ‘type-2 low’, neutrophilic asthma been defined. We performed an integrated species-level metagenomic data with inflammatory mediators to characterise prevalence of dominant potentially pathogenic organisms and host immune responses.
Methods: Sputum and nasal lavage samples were analysed using long-read metagenomic sequencing with Nanopore and qPCR in two cross-sectional adult severe asthma cohorts, Wessex (n=66) and Oxford (n=30). We integrated species-level data with clinical parameters and 39 selected airway proteins measured by immunoassay and O-link.
Results: The sputum microbiome in health and mild asthma displayed comparable microbial diversity. By contrast, 23% (19/81) of severe asthma microbiomes were dominated by a single respiratory pathogen, namely H. influenzae (n=10), M. catarrhalis (n=4), S. pneumoniae (n=4) and P. aeruginosa (n=1). Neutrophilic asthma was associated with H. influenzae, M. catarrhalis, S. pneumoniae and T. whipplei with elevated type-1 cytokines and proteases; eosinophilic asthma with higher M. catarrhalis, but lower H. influenzae, and S. pneumoniae abundance. H. influenzae load correlated with Eosinophil Cationic Protein, elastase and IL-10. R. mucilaginosa associated positively with IL-6 and negatively with FGF. Bayesian network analysis also revealed close and distinct relationships of H. influenzae and M. catarrhalis with type-1 airway inflammation. The microbiomes and cytokine milieu were distinct between upper and lower airways.
Conclusions: This species-level integrated analysis reveals central, but distinct associations between potentially pathogenic bacteria and airways inflammation in severe asthma.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 9.6MB, Terms of use)
-
- Publisher copy:
- 10.1111/all.16269
Authors
- Publisher:
- Wiley
- Journal:
- Allergy More from this journal
- Volume:
- 79
- Issue:
- 11
- Pages:
- 2966-2980
- Publication date:
- 2024-08-11
- Acceptance date:
- 2024-06-19
- DOI:
- EISSN:
-
1398-9995
- ISSN:
-
0105-4538
- Language:
-
English
- Keywords:
- Pubs id:
-
2009908
- Local pid:
-
pubs:2009908
- Deposit date:
-
2024-06-24
Terms of use
- Copyright holder:
- Jabeen et al.
- Copyright date:
- 2024
- Rights statement:
- © 2024 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Notes:
- For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record